Sagone A, Iacopino S, Pieragnoli P, Arena G, Verlato R, Molon G, Rovaris G, Curnis A, Rauhe W, Lunati M, Senatore G, Landolina M, Allocca G, De Servi S, Tondo C
Policlinico IRCCS Multimedica Sesto San Giovanni, Via Milanese, 300, 20099, Sesto San Giovanni, MI, Italy.
Maria Cecilia Hospital, GVM Care & Research Group, Cotignola, Italy.
J Interv Card Electrophysiol. 2019 Sep;55(3):267-275. doi: 10.1007/s10840-018-0500-6. Epub 2019 Jan 3.
Pulmonary vein isolation by cryoablation (PVI-C) is a standard therapy for the treatment of atrial fibrillation (AF); however, PVI-C can become a challenging procedure due to the anatomy of the left atrium and pulmonary veins (PVs). Importantly, the utility of imaging before the procedure is still unknown regarding the long-term clinical outcomes following PVI-C. The aim of the analysis is to evaluate the impact of imaging before PVI-C on procedural data and AF recurrence.
Patients with paroxysmal AF underwent an index PVI-C. Data were collected prospectively in the framework of 1STOP ClinicalService® project. Patients were divided into two groups according to the utilization of pre-procedural imaging of PV anatomy (via CT or MRI) or the non-usage of pre-procedural imaging.
Out of 912 patients, 461 (50.5%) were evaluated with CT or MRI before the PVI-C and denoted as the imaging group. Accordingly, 451 (49.5%) patients had no pre-procedural imaging and were categorized as the no imaging group. Patient baseline characteristics were comparable between the two cohorts, but the ablation centers that comprised the imaging group had fewer PVI-C cases per year than the no imaging group (p < 0.001). The procedure, fluoroscopy, and left atrial dwell times were significantly shorter in the no imaging cohort (p < 0.001). The rates of complications were significantly greater in the imaging group compared to the no imaging group (6.9% vs. 2.7%; p = 0.003); this difference was attributed to differences in transient diaphragmatic paralysis. The 12-month freedom from AF was 76.2% in the imaging group and 80.0% in the no imaging group (p = 0.390).
In our analysis, PVI-C was effective regardless of the availability of imaging data on PV anatomy.
冷冻消融肺静脉隔离术(PVI-C)是治疗心房颤动(AF)的标准疗法;然而,由于左心房和肺静脉(PVs)的解剖结构,PVI-C可能成为一项具有挑战性的手术。重要的是,术前成像对于PVI-C术后长期临床结局的作用仍不明确。本分析的目的是评估PVI-C术前成像对手术数据和AF复发的影响。
阵发性AF患者接受首次PVI-C治疗。数据在1STOP ClinicalService®项目框架内前瞻性收集。根据术前是否利用PV解剖结构成像(通过CT或MRI)将患者分为两组。
在912例患者中,461例(50.5%)在PVI-C术前接受了CT或MRI评估,被归为成像组。相应地,451例(49.5%)患者未进行术前成像,被归为非成像组。两组患者的基线特征具有可比性,但成像组所在的消融中心每年的PVI-C病例数少于非成像组(p < 0.001)。非成像组的手术、透视和左心房停留时间明显更短(p < 0.001)。成像组的并发症发生率明显高于非成像组(6.9%对2.7%;p = 0.003);这种差异归因于短暂性膈肌麻痹的差异。成像组12个月无AF的比例为76.2%,非成像组为80.0%(p = 0.390)。
在我们的分析中,无论是否有PV解剖结构的成像数据,PVI-C都是有效的。